ANORO ELLIPTA inhaler

Anoro Ellipta is a combination prescription medicine used to treat chronic obstructive pulmonary disease (COPD). It consists of two active ingredients, umeclidinium and vilanterol, delivered through the Ellipta dry powder inhaler device. The brand was developed by the British pharmaceutical giant GSK (GlaxoSmithKline plc) in collaboration with Innoviva (formerly Theravance, Inc.).

Manufacturing of the Ellipta device and the filling of the medication primarily takes place at GSK's specialized facilities in the United Kingdom, specifically at their Ware site, though global distribution may involve secondary packaging sites worldwide. GSK remains the ultimate owner and global manufacturer of the product, maintaining its headquarters in London, UK.